针对法布里病的新生儿查:目前的知识状况
Vincenza Gragnaniello1, Alessandro P Burlina2, Anna Commone1
1Division of Inherited Metabolic Diseases, Department of Diagnostic Services, University Hospital, 35128 Padua, Italy.
International journal of neonatal screening
|June 27, 2023
概括
新生儿对法布里病的查使得这种罕见的遗传疾病的早期诊断和治疗成为可能. 持续的随访对于了解疾病进展和优化查效益至关重要.
科学领域:
- 遗传学和罕见疾病.
- 溶酶体储存障碍 溶酶体储存障碍
- 新生儿查方法 新生儿查方法
背景情况:
- 费布里病是一种X链 lysosomal 疾病,由α-galactosidase A 缺乏引起.
- 延迟诊断导致不可逆转的器官损伤和治疗效率降低.
- 新生儿查的目的是早期检测和干预.
研究的目的:
- 审查Fabry病新生儿查的发展和当前状态.
- 讨论诊断方法的进展.
- 突出查的持续挑战和未来方向.
主要方法:
- 在干血斑点上应用标准酶学度方法.
- 开发高通量测试,如数字微流体学和双重质谱学.
- 在精选的新生儿查计划中实施基于DNA的方法.
主要成果:
- 新生儿查已在全球范围内使用各种技术实施.
- 基于酶的方法可能会错过受影响的女性.
- 伦理方面的考虑来自于识别后期出现的形式和不确定的意义的变体.
结论:
- 长期跟踪对于了解疾病的自然史和完善查方案至关重要.
- 提高知识将有助于评估新生儿查法布里病的风险和益处.
- 新生儿查法布里病的普遍接受仍在考虑中.
相关概念视频
01:25Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...